Ronne Yeo, Ph.D.

Chief Scientific Officer

Dr. Ronne Yeo is a co-founder and the Chief Scientific Officer of Carcell Biopharma. He is a biotech investor, inventor and entrepreneur with a track record in leading R&D in a biotech company.


As a founding member and the VP of Discovery at Carmine Therapeutics, Dr. Yeo built and led the research team to create the REGENT™ Platform to enable RBCEV-mediated delivery of large nucleic acid payloads. The team subsequently demonstrated long-term expression and redosing of genetic cargo, providing proof-of-concept for Carmine’s innovative non-viral gene therapy platform. 


Before Carmine and Carcell, Dr. Yeo accumulated 7 years of basic research and pre-clinical development experience on therapeutic EVs derived from mesenchymal stem cells. Dr. Yeo has co-authored 4 research articles and 12 review articles/book chapters related to this work. 


Dr. Yeo obtained his Ph.D. in Biological Sciences from the National University of Singapore.


Ronne Yeo, Ph.D.